Jim Cramer Commented on These 14 Stocks
There is a reason I always hesitate to recommend the hottest stocks in the market, the ones with the parabolic moves, the monstrous one-day gains.
Biocryst Pharmaceuticals Inc (BCRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 15,827,186 | $123,452,051 | 1.26% | |
| 2. | Deerfield Management James E. Flynn | 14,341,000 | $111,859,800 | +18% | 1.43% |
| 3. | Kynam Capital Derrick Tang | 9,366,526 | $73,058,903 | -1% | 4.67% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 4,089,112 | $31,895,074 | -4% | 0.06% |
| 5. | Perceptive Advisors Joseph Edelman | 3,162,529 | $24,667,726 | 0.44% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.36 | 7,861 | $49,995.96 | 44,951 | 2024-05-30 | Filing | |
| $6.40 | 2,500 | $16,000.00 | 2,500 | 2024-05-24 | Filing | |
| $6.38 | 5,000 | $31,900.00 | 86,818 | 2024-05-20 | Filing | |
| $6.25 | 15,000 | $93,750.00 | 66,997 | 2024-05-20 | Filing | |
| $5.57 | 36,300 | $202,191.00 | 266,744 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.65 | 21,773 | $166,563.45 | 398,751 | 2025-12-22 | Filing | |
| $7.65 | 21,210 | $162,256.50 | 315,726 | 2025-12-15 | Filing | |
| $7.65 | 19,770 | $151,240.50 | 345,476 | 2025-12-03 | Filing | |
| $7.21 | 50,906 | $367,215.52 | 365,246 | 2025-12-02 | Filing | |
| $7.10 | 91,004 | $646,510.62 | 416,152 | 2025-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,273,375 | $173,732,325 | 0% | |
| 2. | 21,137,791 | $164,874,767 | 0% | |
| 3. | 11,073,211 | $86,371,046 | 0% | |
| 4. | 7,404,386 | $57,791,233 | 0.03% | |
| 5. | 5,263,914 | $41,058,529 | 0.01% |
News See All
H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best small cap stocks to buy with huge upside potential. H.C. Wainwright lifted the price target on BioCryst Pharmaceuticals Inc.
12 Small Cap Stocks to Buy with Huge Upside Potential
Talking about rotation in the market, she expects the trend to continue for a while, with the capital basically moving from the high multiple mega cap winners towards small caps, cyclicals, and the international...
BioCryst Data Highlights Severe Psychosocial Burden of HAE on Pediatric Patients, Caregivers
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best upside stocks to buy now.
12 Best Upside Stocks to Buy Now
On November 14, Alli McCartney, UBS Private Wealth Management managing director, joined 'Squawk Box' on CNBC to discuss the latest market trends and what to make of the recent volatility.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript November 3, 2025BioCryst Pharmaceuticals, Inc. misses on earnings expectations.
BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best stocks to buy under $20.
10 Best Stocks to Buy Under $20
On September 16, Ali Dibadj, Janus Henderson Investors CEO, joined 'Squawk Box' on CNBC to discuss the latest market trends and suggest that small and mid-cap stocks have enormous potential to deliver...
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge
BioCryst Pharmaceuticals, Inc.
11 Best Pharma Stocks to Invest in for the Long Term
According to a recent White House announcement, President Trump wrote letters to 17 major pharmaceutical companies outlining the actions they could take to bring the prices of prescription pharmaceuticals...
Hedge Fund Resource Center Billionaire Hedge Funds
